S
James Galeota
SVP, General Manager, Diabetes and Obesity, Merck
BIGGEST ACCOMPLISHMENT: Establishing Merck's diabetes franchise
ADMIRES: Those that can help others live up to their potential
On stopping the silos:
Commercialization is not about discreet disciplines. At Merck, I have been able to see into different parts of the company and see the value that can be created when all the divisions are synchronized—when you have teams that are aligned around objectives, sharing the same measures of success, holding each other accountable, and working together to solve complex problems.
James Galeota
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement
April 1st 2025The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to facilitate completion of the NEPHRO CRRT study of Niyad in patients undergoing renal replacement therapy by the end of 2025.